Kimberly-Clark Corporation

πŸ‡ΊπŸ‡ΈNew York Stock Exchange
Back to all articles
Bullish +75

Kimberly-Clark (KMB) Launches New Product Safety Study

πŸ“… Kimberly-Clark (KMB) announced a new clinical trial on May 19, 2026, titled "An Open-Label Applicator Tampon Safety-in-Use Study."

πŸ”¬ The study evaluates the safety of a commercially available tampon across regular, super, and super plus absorbencies during normal use.

πŸ‘₯ The trial is unblinded and actively recruiting volunteers to de-risk product safety within the company's feminine care division.

🎯 This initiative aims to reinforce consumer trust in Kimberly-Clark's core feminine care products.

πŸ‘Ά On May 6, 2026, the company launched the "Natural Born Fighters" campaign for its Huggies brand.

❀️ The campaign recognizes NICU babies' strengths and supports caregivers by reframing fragile infants as "Little Fighters."

πŸ’° KMB declared a regular quarterly dividend of $1.28 per share payable on July 2, 2026.

πŸ“… Shareholders of record as of June 5, 2026 will receive the dividend payment.

πŸ† The dividend announcement marks the company's 92nd consecutive year of dividend payments.

πŸ“ˆ This also represents the 54th consecutive annual dividend increase for Kimberly-Clark.

🏒 Founded in 1872, Kimberly-Clark is a global company based in Texas focused on personal care products.

🌍 The company operates through two main segments: North America and International Personal Care.

⚠️ The article notes that while KMB is an investment option, some AI stocks are suggested as having greater promise for higher returns.

Bullish Signals
  • Kimberly-Clark (KMB) is recognized as one of the 10 Safest Dividend Stocks to Buy Right Now.
  • The company launched a new clinical trial, 'An Open-Label Applicator Tampon Safety-in-Use Study,' aimed at de-risking product safety and reinforcing consumer trust within its core feminine care division.
  • Kimberly-Clark reinforced its core product commitment with the Natural Born Fighters campaign for Huggies, focusing on recognizing NICU babies' strengths and supporting caregivers.
  • The company declared a regular quarterly dividend of $1.28 per share, payable on July 2, 2026, to shareholders of record as of June 5, 2026.
  • This dividend announcement highlights the company's long-term financial stability and marks its 92nd consecutive year of dividend payments.
  • The company has also achieved its 54th consecutive annual dividend increase, demonstrating a strong track record of shareholder returns.
Risk Factors
  • The article explicitly states that while KMB is a safe dividend stock, the author's conviction lies in AI stocks holding greater promise for higher returns within a shorter time frame.
  • The text suggests that if an investor is looking for an AI stock with more promising upside potential than KMB, they should check out a report about another 'cheapest AI stock' instead.
Full Analysis
Kimberly-Clark Corporation (KMB) announced on May 19, 2026, the launch of an open-label clinical trial titled "An Open-Label Applicator Tampon Safety-in-Use Study." The study is actively recruiting volunteers to evaluate the safety of a commercially available tampon, designated as Tampon A, across regular, super, and super plus absorbencies during normal use. This unblinded protocol aims to de-risk product safety and reinforce consumer trust within the company's core feminine care division. Separately, on May 12, 2026, Kimberly-Clark declared a regular quarterly dividend of $1.28 per share, payable on July 2, 2026, to shareholders of record as of June 5, 2026. This announcement highlights the company's long-term financial stability, marking its 92nd consecutive year of dividend payments and its 54th consecutive annual dividend increase. Additionally, the company reinforced its core product commitment on May 6, 2026, with the Natural Born Fighters campaign launched by its Huggies brand, which recognizes NICU babies' strengths and supports caregivers by reframing fragile infants as Little Fighters. Founded in 1872, Kimberly-Clark is a global company focused on personal care products and solutions, based in Texas, operating through North America and International Personal Care segments.